Dianthus Therapeutics, Inc. /DE/ (DNTH)
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.
Address
300 TECHNOLOGY SQUARE
CAMBRIDGE, MA 02139
Founded
2015
Number of Employees
53
Website
http://dianthustx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)